Trevi Therapeutics Inc (NAS:TRVI)
$ 3.3 0 (0%) Market Cap: 239.55 Mil Enterprise Value: 171.25 Mil PE Ratio: 0 PB Ratio: 3.62 GF Score: 41/100

Q3 2022 Trevi Therapeutics Inc Earnings Call Transcript

Nov 10, 2022 / 09:30 PM GMT
Release Date Price: $1.93


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TRVI.OQ - Trevi Therapeutics Inc
Q3 2022 Trevi Therapeutics Inc Earnings Call
Nov 10, 2022 / 09:30PM GMT

=====================
Conference Call Participants
=====================
* >>Jennifer Good - CEO
* >>Lisa Delfini - CFO
* >>Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division
* >>Serge Belanger - Needham & Company, LLC, Research Division

=====================
Presentation
--------------------------------------------------------------------------------
Operator [1]
--------------------------------------------------------------------------------

Good afternoon, and welcome to the Trevi Therapeutics Q3 2022 Earnings Conference Call. (Operator Instructions) Please note, today's event is being recorded.

Various remarks that management makes during this conference call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot